Recent advances in anti-multidrug resistance for nano-drug delivery system

Drug Deliv. 2022 Dec;29(1):1684-1697. doi: 10.1080/10717544.2022.2079771.

Abstract

Chemotherapy for tumors occasionally results in drug resistance, which is the major reason for the treatment failure. Higher drug doses could improve the therapeutic effect, but higher toxicity limits the further treatment. For overcoming drug resistance, functional nano-drug delivery system (NDDS) has been explored to sensitize the anticancer drugs and decrease its side effects, which are applied in combating multidrug resistance (MDR) via a variety of mechanisms including bypassing drug efflux, controlling drug release, and disturbing metabolism. This review starts with a brief report on the major MDR causes. Furthermore, we searched the papers from NDDS and introduced the recent advances in sensitizing the chemotherapeutic drugs against MDR tumors. Finally, we concluded that the NDDS was based on several mechanisms, and we looked forward to the future in this field.

Keywords: Multidrug resistance; nano-drug delivery system; nanoparticles.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm
  • Humans
  • Nanoparticle Drug Delivery System
  • Nanoparticles* / therapeutic use
  • Neoplasms* / drug therapy
  • Neoplasms* / metabolism

Substances

  • Antineoplastic Agents
  • Nanoparticle Drug Delivery System

Grants and funding

The authors thank the Qingdao Science and Technology Demonstration and Guidance Project [21-1-4-rkjk-10-nsh].